3 studies found for:    22045986 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Condition: Low-Grade B-cell Lymphoma
Interventions: Drug: rhuFlt3L/CDX-301;   Drug: Poly-ICLC
2 Completed Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: CPG 7909
3 Withdrawn Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Condition: Mycosis Fungoides
Intervention: Drug: CPG 7909

Indicates status has not been verified in more than two years